At a glance
ClinicalIndex Comparison RecordN/ACompleted· 113 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Transcutaneous Bilirubinometry in Neonates With the Bilicare System
In Brief
An observational study for Transcutaneous Bilirubinometry. Completed, enrolled 113 participants.
Detailed Summary
The purpose of this study is to test the performance of a new transcutaneous ("measured through skin") bilirubin device (BiliCare™) to measure bilirubin levels. The investigators plan to evaluate the clinical performance of this device as a point of care test. If the investigators can validate the BiliCare™ with bilirubin from your baby's blood they could verify a non-invasive alternative for measuring bilirubin.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsTranscutaneous Bilirubinometry
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJun 2014
Primary CompletionMay 2015
First PostedMay 2015
TodayJul 2026
First PostedMay 15, 2015
Enrollment StartJun 1, 2014
Primary CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 11.1 years ago